Cargando…
Modulating glioma-mediated myeloid-derived suppressor cell development with sulforaphane
Glioblastoma is the most common primary tumor of the brain and has few long-term survivors. The local and systemic immunosuppressive environment created by glioblastoma allows it to evade immunosurveillance. Myeloid-derived suppressor cells (MDSCs) are a critical component of this immunosuppression....
Autores principales: | Kumar, Ravi, de Mooij, Tristan, Peterson, Timothy E., Kaptzan, Tatiana, Johnson, Aaron J., Daniels, David J., Parney, Ian F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5493295/ https://www.ncbi.nlm.nih.gov/pubmed/28666020 http://dx.doi.org/10.1371/journal.pone.0179012 |
Ejemplares similares
-
Isolation and Analysis of Plasma-Derived Exosomes in Patients With Glioma
por: Cumba Garcia, Luz M., et al.
Publicado: (2019) -
Antitumor activity of novel pyrazole-based small molecular inhibitors of the STAT3 pathway in patient derived high grade glioma cells
por: Zhang, Liang, et al.
Publicado: (2019) -
Myeloid-derived suppressor cells in gliomas
por: Gieryng, Anna, et al.
Publicado: (2016) -
Current Murine Models and New Developments in H3K27M Diffuse Midline Gliomas
por: Welby, John P., et al.
Publicado: (2019) -
Editorial: Myeloid Derived Suppressor Cells as Disease Modulators
por: Finn, Olivera J., et al.
Publicado: (2020)